Diagnostic imaging devices are used for the visualization of structural and functional patterns of organs or tissues. A Nuclear Imaging agent is a compound, usually based on a drug molecule, that includes a small amount of radioactive material, or radiotracer. Radiotracers generate a signal that can be detected by a gamma (SPECT) camera or a positron emission tomography (PET) scanner. GlobalData uses proprietary data and analytics to provide a comprehensive report on the nuclear imaging agents market in Germany. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the nuclear imaging agents market in Germany was Advanced Accelerator Applications followed by Bracco Diagnostics, Cardinal Health, GE HealthCare Technologies and Lantheus.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
PET Imaging Agents includes Copper-Based PET Imaging Agents, Fluorine-Based PET Imaging Agents, Gallium-68-Based PET Imaging Agents and Rubidium-Based PET Imaging Agents. SPECT Imaging Agents includes Indium-Based SPECT Imaging Agents, Iodine-Based SPECT Imaging Agents, Lutetium-Based SPECT Imaging Agents, Technetium-Based SPECT Imaging Agents and Thallium-Based SPECT Imaging Agents.
The nuclear imaging agents market in Germany can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size nuclear imaging agents in Germany, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
